(1)
Design and Docking of Novel Series of Hybrid Xanthones As Anti-Cancer Agent to Target Human DNA Topoisomerase 2-Alpha. Bangladesh J Pharmacol 2014, 9 (2), 208-217. https://doi.org/10.3329/bjp.v9i2.18180.